Sheela Foam Limited has informed the Exchange about Updated Investor Presentation
© sSleepiell
To
06" August, 2022
The BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai-400001 Scrip Code: 540203
The National Stock Exchange India Limited Exchange Plaza, Bandra Kurla Complex Bandra(E), Mumbai-400051 NSE Symbol: SFL
Subject: Updated investor presentation
Dear Sir/Madam
Furtherance to our earlier communication and results for the quarter and year ended 30" June, 2022, Please find attached updated investor presentation on results.
Thanking you.
Yours faithfully, For Sheela Foam Limited
Gp
(Md. Iquebal Ahmad) Company Secretary and Compliance Officer
SHEELA FOAM LTD.
#14, Sleepwell Tower , Sector 135, Noida- 201301 Ph: Int-91(0)-120-4162200 « Fax: Int-91-(0)-120-4162282, 4162283 +« Email: contactus@sheelafoam.com
Regd. Office: 604 Ashadeep, 9 Hailey Road, New Delhi-110001, India + Ph: Int-91(0)-11-22026875-76 Toll Free: 1800 103 6664 « www.sleepwellproducts.com * www.sheelafoam.com CIN-L74899DL1971 PLC005679
Sheela Foam Ltd.
Earnings Presentation Q1-FY23
Company Snapshot
Experienced Management
‘Sleepwell’ mattresses a household Brand and one of the most trusted brands in India
Backward Integrated Player with a wide product basket
Largest manufacturers of PU Foam in India
20-25% Market Share in the Mattresses segment
40% market share in Australia
Presence across multiple geographies
Low Gearing ratio
Consistent Positive cash flow generation
Strategic move to focus on high margin products
Earnings Presentation August 2022
2
Marquee Investors
Proven track record in Acquisitions and Integration
•
•
•
•
•
•
35, 000
30, 000
25, 000
20, 000
15, 000
10, 000
5, 000
-
Company Overview
Incorporated in 1971, Sheela Foam is the market leader and the largest manufacturer of Polyurethane Foam (PU) in India.
India Operations
The Company manufactures various foam-based home comfort products like mattresses, Furniture cushions, as well as technical grades of polyurethane foams for end-use in a range of industries like automobile, acoustics, etc.
The flagship household brands include: ‘Sleepwell’ for mattresses and home comfort, ‘Feather Foam’ a pure PU Foam and ‘Lamiflex’ a polyester foam for lamination.
11
Manufacturing Plants
The company has a global manufacturing footprint with 11 nationwide manufacturing plants in India, 5 in Australia, and 1 in Spain.
It has a strong presence and market share in Australia through its wholly-owned subsidiary, Joyce Foam Pty Ltd. and also in Spain through its subsidiary, Interplasp S.L.,
The company has an integrated manufacturing facility 123,000 MTPA with a robust distribution network of 100+ exclusive distributors, 5,400+ exclusive brand outlets, and 7,850+ multi-brand outlets.
Revenue , EBITDA and EBITDA Margins (INR Mn)
Q1-FY23 Revenue Breakup
123,000
MTPA of Total Capacity
20 – 25%
Market share in India
29,818
Geographical Distribution
Business Segment Distribution
Global Operations
21,414
21,736
24,372
14.94%
9.85%
2,109
13.82%
10.56%
7,291
9.02%
3,004
3,642
3,149
658
14%
15%
19%
71%
81%
FY19
FY20
FY21
FY22
Q1-FY23
Revenues
EBITDA
EBITDA Margins
India Europe
Australia
Home Comfort
Technical Foam
Earnings Presentation August 2022
5
Manufacturing plants in Australia with a capacity of 11,000 MTPA
40%
Market share in Australia
1
Manufacturing plant in Spain with a capacity of 22,000 MTPA to cater to European and US markets
3
Q1-FY23 Performance Highlights
Earnings Presentation August 2022
4
Q1-FY23 Financial and Operational Highlights
Q1-FY23 Consolidated Financial Performance
INR 658 Mn
EBITDA
INR 425 Mn
Net Profit
INR 7,291 Mn Revenue from Operations
9.02%
EBITDA Margin
5.83%
PAT Margin
EBITDA
Net Profit
INR 8.72 Basic/ Diluted EPS
INR 44.83 Basic/ Diluted EPS
•
•
•
•
•
•
•
•
Q1-FY23 Operational Highlights
Strong start to the financial year with 32% YoY growth in Revenue from Operations and 69% YoY growth in Profit after Tax
India & Australia operations registered strong growth while Spain’s growth was impacted due to external challenges in Europe
YoY margin improvement was driven by reduction in key raw material costs, with Polyol prices gradually came down while TDI prices reducing in the beginning of the quarter but went up again towards the end of the quarter
Sleepwell presented its 360-degree retail offering at the HGH 2022 annual trade show with the tagline ‘Leap of Change’ which received a very positive response
The company made an entry into a new network with Sleepwell cushioning partners for Feather foam Mattresses and furniture cushioning
Mid-term Outlook
India & Australia - inflation is impacting consumer sentiments; growth is expected to be moderate
External factors in Europe will have impact on Spain operation. We will focus on growing into new industrial segment and funnel new customers in Madrid + Barcelona
Polyol & TDI Prices will positively impact sequential margins in coming quarters
Earnings Presentation August 2022
5
Q1-FY23 Geographical Revenues
SFL India (INR Mn)
Australia - Joyce (INR Mn)
Spain - Interplasp (INR Mn)
Consolidated (INR Mn)
6, 000
5, 000
4, 000
3, 000
2, 000
1, 000
-
3,257
5.71%
192
5,144
15. 00%
1, 200
13. 00%
11. 00%
9. 00%
1, 000
800
1,034
1,103
11.90%
8.73%
7. 00%
600
8.61%
5. 00%
3. 00%
1. 00%
400
200
383
1,225
5.55%
15. 00%
1, 400
13. 00%
1, 200
11. 00%
1, 000
9. 00%
7. 00%
5. 00%
3. 00%
1. 00%
800
600
400
200
1,046
8.98%
15. 00%
8, 000
13. 00%
7, 000
11. 00%
6, 000
9. 00%
5, 000
7. 00%
4, 000
5. 00%
3, 000
3. 00%
2, 000
1. 00%
1, 000
7,291
9.02%
5,513
6.95%
28
1
42
50
251
425
Q1-FY22
Q1-FY23
Q1-FY22
Q1-FY23
Q1-FY22
Q1-FY23
Q1-FY22
Q1-FY23
- 1.00%
-
- 1.00%
-
- 1.00%
-
Revenues
PAT
EBITDA Margins
Revenues
PAT
EBITDA Margins
Revenues
PAT
EBITDA Margins
Revenues
PAT
EBITDA Margins
Earnings Presentation August 2022
15. 00%
13. 00%
11. 00%
9. 00%
7. 00%
5. 00%
3. 00%
1. 00%
- 1.00%
6
Mattresses (INR Mn)
Furniture Foam (INR Mn)
Technical Foam (INR Mn) Technical Foam
Comfort Foam and HC Line (INR Mn)
Q1-FY23 Business Segment Revenues
57.1%
2,195
1,397
62.9%
627
64.8%
1,236
385
750
48.8%
1,077
724
Q1-FY22
Q1-FY23
Q1-FY22
Q1-FY23
Q1-FY22
Q1-FY23
Q1-FY22
Q1-FY23
Mattresses (Volumes in 000’s)
Furniture Foam (Volumes in MT)
Technical Foam (Volumes in MT) Technical Foam
Comfort Foam (Volumes in MT)
43.1%
501
54.6%
1,302
350
842
51.1%
3,313
2,192
53.1%
4,942
3,229
Q1-FY22
Q1-FY23 Earnings Presentation August 2022
Q1-FY22
Q1-FY23
Q1-FY22
Q1-FY23
Q1-FY22
Q1-FY23
7
Raw Material Prices and Gross Margins
TDI & Polyol Price Trend
SFL Consolidated Gross Margins (%)
217
210
212
203
200
173
267
227
178
174
39.9%
39.1%
37.4%
39.8%
35.5%
Q1-FY22
Q2-FY22
Q3-FY22
Q4-FY22
Q1-FY23
TDI
POLYOL
Q1-FY22
Q2-FY22
Q3-FY22
Q4-FY22
Q1-FY23
SFL India
41.1%
39.7%
40.3%
37.0%
36.7%
Gross Margins (%)
Australia - Joyce
54.1%
50.6%
50.1%
52.1%
Spain - Interplasp
48.1%
23.5%
24.0%
16.6%
26.0%
20.1%
Q1-FY22 Q2-FY22 Q3-FY22 Q4-FY22 Q1-FY23
Q1-FY22 Q2-FY22 Q3-FY22 Q4-FY22 Q1-FY23
Q1-FY22 Q2-FY22 Q3-FY22 Q4-FY22 Q1-FY23
Earnings Presentation August 2022
8
Quarterly Standalone Financial Performance
Particulars (INR Mn)
Revenue from Operations
Operating Expenses
EBITDA
EBITDA Margin (%)
Other Income
Depreciation
Finance Cost
PBT
Tax
PAT
Q1-FY23
Q1-FY22
5,144
4,695
449
8.73%
163
73
23
516
133
383
3,257
3,071
186
5.71%
148
74
25
235
43
192
PAT Margin (%)
7.45%
5.89%
Other Comprehensive Income
Total Comprehensive Income
Basic/Diluted EPS (INR)
Earnings Presentation August 2022
(35)
348
7.85
24
216
3.94
Y-O-Y
57.9%
52.9%
NA
302 Bps
10.1%
(1.4)%
(8.0)%
NA
NA
99.5%
156 Bps
NA
61.1%
99.2%
Q4-FY22
5,637
5,087
550
9.76%
151
86
7
608
134
474
8.41%
(63)
411
9.71
Q-O-Q
(8.7)%
(7.7)%
(18.4)%
(103) Bps
7.9%
(15.1)%
NA
(15.1)%
(0.7)%
(19.2)%
(96) Bps
(44.4)%
(15.3)%
(19.2)%
9
Particulars (INR Mn)
Revenue from Operations
Operating Expenses
EBITDA
EBITDA Margin (%)
Other Income
Depreciation
Finance Cost
PBT
Tax
PAT
Quarterly Consolidated Financial Performance
Q1-FY23
Q1-FY22
7,291
6,633
658
9.02%
184
206
52
584
159
425
5,513
5,130
383
6.95%
179
185
49
327
76
251
Y-O-Y
32.3%
29.3%
71.8%
207 Bps
2.8%
11.4%
6.1%
78.6%
NA
69.3%
PAT Margin (%)
5.83%
4.55%
128 Bps
Other Comprehensive Income
Total Comprehensive Income
Basic/Diluted EPS (INR)
Earnings Presentation August 2022
(66)
359
8.72
25
276
5.15
NA
30.1%
69.3%
Q4-FY22
7,636
6,918
718
9.41%
158
237
21
618
125
493
6.46%
(67)
426
10.11
Q-O-Q
(4.5)%
(4.1)%
(8.4)%
(39) Bps
16.5%
(13.1)%
NA
(5.5)%
27.2%
(13.8)%
(63) Bps
(1.5)%
(15.7)%
(13.7)%
10
Historical Financial Overview
Earnings Presentation August 2022
11
PARTICULARS (INR Mn)
Operational Revenue
Operating Expenses
EBITDA
EBITDA Margins (%)
Other Income
Depreciation
Finance Cost
PBT
Exceptional Items
Tax
PAT
PAT Margins (%)
Other Comprehensive Income
Total Comprehensive Income
Diluted EPS (INR)
Earnings Presentation August 2022
Historical Standalone Income Statement
FY19
18,138
16,302
1,835
10.12%
305
311
73
1,756
-
519
1,237
6.82%
(9)
1,228
25.35
FY20
17,548
15,278
2,270
12.94%
413
331
81
2,271
120
496
1,655
9.43%
(43)
1,612
33.93
FY21
16,939
14,566
2,373
14.01%
474
325
87
2,435
-
623
1,812
10.70%
21
1,833
37.13
FY22
21,244
18,906
2,338
11.01%
702
324
71
2,645
-
673
1,973
9.29%
(12)
1,961
40.45
Q1-FY23
5,144
4,695
449
8.73%
163
73
23
516
-
133
383
7.45%
(35)
348
7.85
12
PARTICULARS (INR Mn)
ASSETS
Non-current Assets Property, Plant & Equipment Capital Work In Progress Right of Use Assets Investment Property Investment In Subsidiaries Financial Assets (a) Investments (b) Loans (c) Other Financial Assets (d) Investment in Preference Shares Non-current Assets (Net) Other Non Current Assets Current Assets Inventories Financial Assets (a) Investments (b) Trade Receivable (c) Cash And Cash Equivalent (d) Other Bank Balances (e) Loans (f) Other Current Fin Assets Other Current Assets GRAND TOTAL – ASSETS Earnings Presentation August 2022
FY19
4,334 2,654 7 - 38 994
492 23 1 - 106 19 5,895 1,530
2,677 1,026 107 16 1 257 281 10,229
Historical Standalone Balance Sheet FY20
PARTICULARS (INR Mn)
FY21
FY22
5,808 2,542 165 211 37 2,137
118 485 3 - 96 14 5,887 1,652
2,179 1,264 289 2 56 100 345 11,695
8,497 2,536 12 201 38 2,137
3,036 486 21 - 3 26 5,713 2,283
1,060 1,630 350 5 56 87 241 14,210
11,159 2,350 6 184 36 1,967
5,288 778 180 299 45 26 5,079 2,035
840 1,516 143 3 56 293 194 16,238
EQUITY & LIABILITIES
Equity
(A) Share Capital
(B) Other Equity
Non-current Liabilities
Financial Liabilities
(A) Borrowings
(B) Lease Liabilities
(C) Other Financial Liabilities
Provisions
Deferred Tax Liabilities (Net)
Other Non Current Liabilities
Current Liabilities
Financial Liabilities
(A) Borrowings
(B) Lease Liabilities
(C) Trade Payables
(D) Other Current Fin Liabilities
Provisions
Other Current Liabilities
GRAND TOTAL - EQUITIES & LIABILITES
FY19
FY20
FY21
FY22
6,691
244
6,447
882
3
-
697
68
114
-
8,301
10,134
12,095
244
8,057
904
244
244
9,890
11,851
653
877
-
25
737
73
69
-
-
19
502
46
83
3
-
183
503
141
48
2
2,656
2,490
3,423
3,266
-
-
-
2
-
1
-
11
1,165
1,141
2,333
2,095
743
49
699
739
55
553
381
44
664
413
25
722
10,229
11,695
14,210
16,238
13
PARTICULARS (INR Mn)
Operational Revenue
Operating Expenses
EBITDA
EBITDA Margins (%)
Other Income
Depreciation
Finance Cost
PBT
Exceptional Items
Tax
PAT
PAT Margins (%)
Other Comprehensive Income
Total Comprehensive Income
Diluted EPS (INR)
Earnings Presentation August 2022
Historical Consolidated Income Statement
FY19
21,414
19,305
2,109
9.85%
276
395
96
1,894
-
557
1,337
6.24%
(9)
1,328
27.41
FY20
21,736
18,732
3,004
13.82%
400
590
130
2,684
120
621
1,943
8.94%
(31)
1,912
39.83
FY21
24,372
20,730
3,642
14.94%
502
729
177
3,238
-
837
2,402
9.86%
188
2,590
49.23
FY22
29,818
26,669
3,149
10.56%
792
808
169
2,964
-
776
2,187
7.33%
(18)
2,169
44.83
Q1-FY23
7,291
6,633
658
9.02%
184
206
52
584
-
159
425
5.83%
(66)
359
8.72
14
PARTICULARS (INR Mn)
ASSETS
Non-current Assets Property, Plant & Equipment
Capital Work In Progress Right of Use Assets Investment Property Goodwill Financial Assets (a) Investments (b) Loans
(c) Other Non Current Fin Assets Non-current Assets (Net)
Other Non Current Assets Current Assets Inventories Financial Assets
(a) Investments (b) Trade Receivable
(c) Cash And Cash Equivalent (d) Other Bank Balances
(e) Loans (f) Other Current Fin Assets Other Current Assets GRAND TOTAL – ASSETS
FY19
4,761 3,396
7 0 639 82
492 29
11 87
18 6,857 1,871
2,684 1,522
168 35
2 257 318 11,618
Historical Consolidated Balance Sheet FY20
PARTICULARS (INR Mn)
FY21
FY22
8,870 4,204
180 1,167 590 2,546
118 26
21 5
13 7,569 2,269
2,196 2,158
441 5
56 55 389 16,439
12,381 4,300
15,511 4,355
326 1,418 590 2,631
3,036 2
52 -
26 8,313 3,153
1,070 3,021
574 7
56 69 363 20,694
1,199 1,394 562 2,520
5,288 1
45 67
80 8,213 3,145
893 2,850
408 3
56 264 594 23,724
EQUITY & LIABILITIES
Equity
(A) Share Capital
(B) Other Equity Non Controlling Interest Non-current Liabilities
Financial Liabilities
(A) Borrowings
(B) Lease Liabilities
(C) Other Non Current Financial Liabilities
Provisions
Other Non current Liabilities
Deferred Tax Liabilities (Net)
Current Liabilities
Financial Liabilities
(A) Borrowings
(B) Lease Liabilities
(C) Trade Payables
(D) Other Current Fin Liabilities
Provisions
Current Tax Liabilities (Net)
Other Current Liabilities GRAND TOTAL - EQUITIES & LIABILITES
FY19
FY20
FY21
FY22
7,301
9,264
11,932
14,002
244
7,057 - 896
55
-
696
80
-
65
244
8,953 67 3,328
1,571
824
737
86
-
110
244
244
11,599 89 3,068
13,682 76 4,136
1,326
1,086
502
62
3
89
2,282
1,057
503
274
2
18
3,421
3,847
5,694
5,586
227
0
1,432
913
129
-
720
360
159
1,534
1,075
129
-
590
11,618 16,439
730
201
1,096
231
3,301
3,013
531
147
45
454
25
-
739 20,694
768 23,724
Earnings Presentation August 2022
15
Consolidated Financial Performance
Revenues (INR Mn)
EBITDA (INR Mn) and EBITDA Margins (%)
PAT (INR Mn) and PAT Margins (%)
29,818
21,414
21,736
24,372
3,642
3,004
3,149
14.94%
13.82%
2,109
9.85%
10.56%
9.02%
658
4, 000
3, 500
3, 000
2, 500
2, 000
1, 500
1, 000
500
-
30. 00%
25. 00%
20. 00%
15. 00%
10. 00%
5. 00%
0. 00%
7,291
2,402
2,187
1,943
1,337
6.24%
8.94%
9.86%
7.33%
5.83%
425
3, 000
2, 500
2, 000
1, 500
1, 000
500
-
30. 00%
25. 00%
20. 00%
15. 00%
10. 00%
5. 00%
0. 00%
FY19
FY20
FY21
FY22
Q1-FY23
FY19
FY20
FY21
EBITDA
FY22 Q1-FY23 EBITDA Margins
FY19
FY20
FY21
PAT
FY22 Q1-FY23 PAT Margins
Net Debt to Equity Ratio (x)
Networth (INR Mn)
ROE and ROCE (%)
0.21
0.16
0.12
9,264
7,301
14,002
11,932
0.01
FY19
FY20
FY21
FY22
FY19
FY20
FY21
FY22
Earnings Presentation August 2022
20.9%
21.0%
20.1%
18.3%
19.2%
19.4%
15.6%
12.9%
FY19
FY20
FY21
FY22
ROE
ROCE
16
Capital Market Information
1-Year Stock Performance (Up to 30th June 2022)
80%
70%
60%
50%
40%
30%
20%
10%
0%
-10%
Jul-21
Aug-21
Sep-21
Oct-21
Nov-21
Dec-21
Jan-22
Sheela Foam
Midcap Index
Feb-22
Sensex
Mar-22
Apr-22
May-22
Jun-22
Shareholding Pattern as on 30th June 2022
Price Data as on 30th June, 2022
Face Value
CMP
52 Week H/L
Market Cap (INR Mn)
No. of Share outstanding (Mn)
1 Year Avg. Trading Volume (000)
INR
5.00
2,653.8
4,054 / 2,195
129,462
48.8
32.3
Promoters 72.95%
Mutual Funds 22.57%
Public 1.10%
Foreign Portfolio Investors 3.11%
AIF 0.26%
Earnings Presentation August 2022
17
Disclaimer
No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the date of this presentation. Certain statements made in this presentation may not be based on historical information or facts and may be "forward looking statements" based on the currently held beliefs and assumptions of the management Sheela Foam Limited (“Company” or “Sheela Foam Ltd.”), which are expressed in good faith and in their opinion reasonable, including those relating to the Company’s general business plans and strategy, its future financial condition and growth prospects and future developments in its industry and its competitive and regulatory environment.
Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, financial condition, performance or achievements of the Company or industry results to differ materially from the results, financial condition, performance or achievements expressed or implied by such forward-looking statements, including future changes or developments in the Company’s business, its competitive environment and political, economic, legal and social conditions. Further, past performance is not necessarily indicative of future results. Given these risks, uncertainties and other factors, viewers of this presentation are cautioned not to place undue reliance on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements to reflect future events or developments.
This presentation is for general information purposes only, without regard to any specific objectives, financial situations or informational needs of any particular person. This presentation does not constitute an offer or invitation to purchase or subscribe for any securities in any jurisdiction, including the United States. No part of it should form the basis of or be relied upon in connection with any investment decision or any contract or commitment to purchase or subscribe for any securities. None of our securities may be offered or sold in the United States, without registration under the U.S. Securities Act of 1933, as amended, or pursuant to an exemption from registration there from.
This presentation is confidential and may not be copied or disseminated, in whole or in part, and in any manner.
Valorem Advisors Disclaimer: Valorem Advisors is an Independent Investor Relations Management Service company. This Presentation has been prepared by Valorem Advisors based on information and data which the Company considers reliable, but Valorem Advisors and the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. Valorem Advisors also hereby certifies that the directors or employees of Valorem Advisors do not own any stock in personal or company capacity of the Company under review.
For further information please contact our Investor Relations Representatives: Mr. Anuj Sonpal Valorem Advisors Tel: +91-22-4903-9500 Email: sheela@valoremadvisors.com
Earnings Presentation August 2022
18
THANK YOU
Earnings Presentation August 2022
19